Home > Drug Search >
  • company_query: 4-Antibody
  •   > 
Drug Filter
Category:
chemistry (5) biology (35)
Status:
Approved (4) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (16) Phase Ⅰ (14) IND Filing (1)
Clinical Stage:
Pending (2) Active (30) Discontinued (4)
Bio-Type:
Gene therapy (2) Cell therapy (1) Vaccine (1) Recombinant polypeptide (1) Recombinant coagulation factor (2) Recombinant cytokines (7) Recombinant hormone (2) Whole antibody (2) Fab fragment (1)
Indication:
Acute myeloid Leukemia (AML) (1) Anemia (3) Asthma (1) Breast cancer (2) Cystic fibrosis (CF) (1) Diabetic nephropathy (1) Transplant rejection (1) Growth hormone deficit (1) HBV infection (1) HCV infection (2) HIV infection (1) Leukemia (1) Melanoma (2) Chemotherapy-induced anaemia (1) Multiple myeloma (MM) (2) Systemic amyloidosis (2) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (2) Ovarian cancer (3) Pneumonia (1) Postmenopausal osteoporosis (1) Psoriasis (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Solid tumours (4) Thrombocytopenia (1) Thyroid cancer (1) Type 2 diabetes (1) Head and neck cancer (1) Colorectal cancer (1) Fallopian tube cancer (1) Hemophilia A (2) Neutropenia (2) Hematological cancer (2) Sepsis (1) Peritoneum cancer (1) Staphylococcal infection (1) Glioblastoma (1) Liposarcoma (1) Diffuse large B cell lymphoma (1) Stargardt’s disease (1) Gastrointestinal cancer (1) Cerebral haemorrhage (1)
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top